We are live on
!
Find out more
CC
Carlson Capital Portfolio holdings
AUM
$318M
1-Year Est. Return
27.64%
This Fund
S&P 500
This Quarter
Est. Return
+14.38%
1 Year Est. Return
+27.64%
3 Year Est. Return
+72.52%
5 Year Est. Return
+198.38%
10 Year Est. Return
+1,031.43%
AUM
$1.31B
AUM Growth
-$16.8M
(-1.3%)
Cap. Flow
-$96.4M
Cap. Flow
% of AUM
-7.36%
Top 10 Holdings %
Top 10 Hldgs %
43.8%
Holding
161
New
41
Increased
34
Reduced
40
Closed
44
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$62.7M |
| 2 |
MYOV
Myovant Sciences Ltd.
MYOV
|
+$47.5M |
| 3 |
AUY
Yamana Gold, Inc.
AUY
|
+$31.1M |
| 4 |
POSH
Poshmark, Inc. Class A Common Stock
POSH
|
+$27.8M |
| 5 |
AJRD
Aerojet Rocketdyne Holdings
AJRD
|
+$24.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rogers Corp
ROG
|
+$62.9M |
| 2 |
DRE
Duke Realty Corp.
DRE
|
+$45.8M |
| 3 |
TWTR
Twitter, Inc.
TWTR
|
+$44.6M |
| 4 |
CCXI
ChemoCentryx, Inc.
CCXI
|
+$38.7M |
| 5 |
JPMorgan Chase
JPM
|
+$35.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 32.5% |
| 2 | Technology | 15.54% |
| 3 | Industrials | 13.1% |
| 4 | Healthcare | 11.08% |
| 5 | Consumer Discretionary | 11.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Taysha Gene Therapies
TSHA
$1.69B
| $1.27M | 0.1% |
560,000
+360,000
| +180% | +$729K |
|
102
Iovance Biotherapeutics
IOVA
$2.09B
| $1.16M | 0.09% |
182,109
+7,109
| +4% | +$55.5K |
|
|
APTO
103
DELISTED
Aptose Biosciences, Inc.
APTO
| $1.14M | 0.09% |
4,356
-111
| -2% | -$29.8K |
|
104
Cue Biopharma
CUE
$128M
| $1.04M | 0.08% |
12,167
-5,666
| -32% | -$518K |
|
105
PUT
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.9B
| $956K | 0.07% |
7,500
-2,000
| -21% | -$147K |
|
106
uniQure
QURE
$2.93B
| $907K | 0.07% |
40,000
-20,000
| -33% | -$431K |
|
107
Lantern Pharma
LTRN
$33.8M
| $834K | 0.06% |
138,000
-30,000
| -18% | -$150K |
|
108
Cognition Therapeutics
CGTX
$82M
| $483K | 0.04% |
229,900
+129,900
| +130% | +$262K |
|
109
CALL
SPDR Gold Trust
GLD
$133B
| $399K | 0.03% |
+700
| New | +$113K |
|
110
PUT
Invesco QQQ Trust
QQQ
$450B
| $398K | 0.03% |
1,000
+300
| +43% | +$83K |
|
111
iShares MSCI Brazil ETF
EWZ
$9.25B
| $392K | 0.03% |
+14,000
| New | +$428K |
|
|
LITS
112
Lite Strategy Inc
LITS
$33.6M
| $287K | 0.02% |
59,000
+1,500
| +3% | +$9.77K |
|
113
Roblox
RBLX
$34.8B
| $285K | 0.02% |
+10,000
| New | +$351K |
|
114
Exicure
XCUR
$10M
| $244K | 0.02% |
42,457
+4,457
| +12% | +$27.6K |
|
|
JJC
115
DELISTED
iPath Series B Bloomberg Copper Subindex Total ReturnSM ETN
JJC
| $194K | 0.01% |
+10,000
| New | +$183K |
|
|
TE
116
T1 Energy
TE
$1.19B
| $86.8K | 0.01% |
+10,000
| New | +$125K |
|
|
EIGR
117
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $82.6K | 0.01% |
2,333
+500
| +27% | +$60.1K |
|
118
Aon
AON
$78.3B
| – | – |
-11,100
| Closed | -$2.97M |
|
119
AB InBev
BUD
$166B
| – | – |
-10,800
| Closed | -$488K |
|
120
Cheesecake Factory
CAKE
$5.03B
| – | – |
-21,523
| Closed | -$630K |
|
121
Cullen/Frost Bankers
CFR
$10.3B
| – | – |
-36,500
| Closed | -$4.83M |
|
122
D.R. Horton
DHI
$40.7B
| – | – |
-84,336
| Closed | -$5.68M |
|
123
Domino's
DPZ
$11.7B
| – | – |
-2,300
| Closed | -$713K |
|
124
Euronet Worldwide
EEFT
$2.92B
| – | – |
-26,100
| Closed | -$1.98M |
|
125
Elanco Animal Health
ELAN
$13.2B
| – | – |
-425,000
| Closed | -$5.27M |
|
Similar funds
WIS
SFCM
TM
GWP
CPW
KI
CPH
JWM
Carlson Capital's Q4 2022 Portfolio in Review
As of Q4 2022, Carlson Capital held 161 positions worth $1.31B, down 1.3% from $1.33B the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Carlson Capital withdrew a net $96.4M in Q4 2022, closing 44 positions and reducing 40 holdings. Its most notable exit was Rogers Corp, an estimated $62.9M position sold in full.
By sector, the portfolio is most concentrated in Financials at 32% of assets, down from 34% a quarter earlier, followed by Technology and Industrials.
Against the trend, Carlson Capital opened a new position in Horizon Therapeutics Public Limited Company Ordinary Shares worth $85.9M.
- Carlson Capital's largest Q4 2022 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 755,000 shares worth $85.9M.
- Carlson Capital added most to Lowe's Companies in Q4 2022, an estimated $17.6M increase.
- Carlson Capital's biggest Q4 2022 reduction was Fifth Third Bancorp, cutting an estimated $22.3M.
- Carlson Capital fully exited Rogers Corp in Q4 2022, selling an estimated $62.9M.
- Carlson Capital's ten largest holdings make up 44% of its $1.31B portfolio in Q4 2022.
- Carlson Capital opened 41 new positions and closed 44 in Q4 2022.
- Carlson Capital's portfolio value fell 1.3% quarter-over-quarter to $1.31B.
Based on Carlson Capital's 13F filing for Q4 2022, filed 14 Feb 2023.